The global Next Generation Antibody Therapeutics market is projected to grow from US$ 12260 million in 2023 to US$ 39450 million by 2029, at a Compound Annual Growth Rate (CAGR) of 21.5% during the forecast period.

Next Generation Antibody Therapeutics Market

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

Market Analysis and Insights: Global Next Generation Antibody Therapeutics Market

Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 percent.

Report Includes

This report presents an overview of global market for Next Generation Antibody Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Next Generation Antibody Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next Generation Antibody Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next Generation Antibody Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Next Generation Antibody Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Next Generation Antibody Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Immunomedics and GSK, etc.

Scope of Next Generation Antibody Therapeutics Market Report

Report Metric	Details
Report Name	Next Generation Antibody Therapeutics Market
Accounted market size in 2023	US$ 12260 million
Forecasted market size in 2029	US$ 39450 million
CAGR	21.5
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Antibody Drug Conjugate (ADC) Bispecific Antibody (BsAb)
Segment by Application	Cancer Haemophilia Other Non-Cancer Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Immunomedics, GSK, Immunocore, ADC Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Next Generation Antibody Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Antibody Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next Generation Antibody Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Next Generation Antibody Therapeutics Market growing?

Ans: The Next Generation Antibody Therapeutics Market witnessing a CAGR of 21.5 during the forecast period 2023-2029.

What is the Next Generation Antibody Therapeutics Market size in 2029?

Ans: The Next Generation Antibody Therapeutics Market size in 2029 will be US$ 39450 million.

What is the market share of major companies in Next Generation Antibody Therapeutics Market?

Ans: The top two players hold a share over 70%.

What is the Next Generation Antibody Therapeutics Market share by region?

Ans: North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately.

What is the Next Generation Antibody Therapeutics Market share by type?

Ans: In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 percent.

Who are the main players in the Next Generation Antibody Therapeutics Market report?

Ans: The main players in the Next Generation Antibody Therapeutics Market are Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Immunomedics, GSK, Immunocore, ADC Therapeutics

What are the Application segmentation covered in the Next Generation Antibody Therapeutics Market report?

Ans: The Applications covered in the Next Generation Antibody Therapeutics Market report are Cancer, Haemophilia, Other Non-Cancer Diseases

What are the Type segmentation covered in the Next Generation Antibody Therapeutics Market report?

Ans: The Types covered in the Next Generation Antibody Therapeutics Market report are Antibody Drug Conjugate (ADC), Bispecific Antibody (BsAb)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Antibody Drug Conjugate (ADC)

1.2.3 Bispecific Antibody (BsAb)

1.3 Market by Application

1.3.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Cancer

1.3.3 Haemophilia

1.3.4 Other Non-Cancer Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Antibody Therapeutics Market Perspective (2018-2029)

2.2 Global Next Generation Antibody Therapeutics Growth Trends by Region

2.2.1 Next Generation Antibody Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Next Generation Antibody Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Next Generation Antibody Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Next Generation Antibody Therapeutics Market Dynamics

2.3.1 Next Generation Antibody Therapeutics Industry Trends

2.3.2 Next Generation Antibody Therapeutics Market Drivers

2.3.3 Next Generation Antibody Therapeutics Market Challenges

2.3.4 Next Generation Antibody Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Next Generation Antibody Therapeutics by Players

3.1.1 Global Next Generation Antibody Therapeutics Revenue by Players (2018-2023)

3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Next Generation Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Next Generation Antibody Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Next Generation Antibody Therapeutics Market Concentration Ratio

3.4.1 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Antibody Therapeutics Revenue in 2022

3.5 Global Key Players of Next Generation Antibody Therapeutics Head office and Area Served

3.6 Global Key Players of Next Generation Antibody Therapeutics, Product and Application

3.7 Global Key Players of Next Generation Antibody Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Antibody Therapeutics Breakdown Data by Type

4.1 Global Next Generation Antibody Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2024-2029)

5 Next Generation Antibody Therapeutics Breakdown Data by Application

5.1 Global Next Generation Antibody Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Next Generation Antibody Therapeutics Market Size (2018-2029)

6.2 North America Next Generation Antibody Therapeutics Market Size by Type

6.2.1 North America Next Generation Antibody Therapeutics Market Size by Type (2018-2023)

6.2.2 North America Next Generation Antibody Therapeutics Market Size by Type (2024-2029)

6.2.3 North America Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

6.3 North America Next Generation Antibody Therapeutics Market Size by Application

6.3.1 North America Next Generation Antibody Therapeutics Market Size by Application (2018-2023)

6.3.2 North America Next Generation Antibody Therapeutics Market Size by Application (2024-2029)

6.3.3 North America Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

6.4 North America Next Generation Antibody Therapeutics Market Size by Country

6.4.1 North America Next Generation Antibody Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Next Generation Antibody Therapeutics Market Size by Country (2018-2023)

6.4.3 North America Next Generation Antibody Therapeutics Market Size by Country (2024-2029)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Next Generation Antibody Therapeutics Market Size (2018-2029)

7.2 Europe Next Generation Antibody Therapeutics Market Size by Type

7.2.1 Europe Next Generation Antibody Therapeutics Market Size by Type (2018-2023)

7.2.2 Europe Next Generation Antibody Therapeutics Market Size by Type (2024-2029)

7.2.3 Europe Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

7.3 Europe Next Generation Antibody Therapeutics Market Size by Application

7.3.1 Europe Next Generation Antibody Therapeutics Market Size by Application (2018-2023)

7.3.2 Europe Next Generation Antibody Therapeutics Market Size by Application (2024-2029)

7.3.3 Europe Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

7.4 Europe Next Generation Antibody Therapeutics Market Size by Country

7.4.1 Europe Next Generation Antibody Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Next Generation Antibody Therapeutics Market Size by Country (2018-2023)

7.4.3 Europe Next Generation Antibody Therapeutics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Next Generation Antibody Therapeutics Market Size (2018-2029)

8.2 China Next Generation Antibody Therapeutics Market Size by Type

8.2.1 China Next Generation Antibody Therapeutics Market Size by Type (2018-2023)

8.2.2 China Next Generation Antibody Therapeutics Market Size by Type (2024-2029)

8.2.3 China Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

8.3 China Next Generation Antibody Therapeutics Market Size by Application

8.3.1 China Next Generation Antibody Therapeutics Market Size by Application (2018-2023)

8.3.2 China Next Generation Antibody Therapeutics Market Size by Application (2024-2029)

8.3.3 China Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Next Generation Antibody Therapeutics Market Size (2018-2029)

9.2 Asia Next Generation Antibody Therapeutics Market Size by Type

9.2.1 Asia Next Generation Antibody Therapeutics Market Size by Type (2018-2023)

9.2.2 Asia Next Generation Antibody Therapeutics Market Size by Type (2024-2029)

9.2.3 Asia Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

9.3 Asia Next Generation Antibody Therapeutics Market Size by Application

9.3.1 Asia Next Generation Antibody Therapeutics Market Size by Application (2018-2023)

9.3.2 Asia Next Generation Antibody Therapeutics Market Size by Application (2024-2029)

9.3.3 Asia Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

9.4 Asia Next Generation Antibody Therapeutics Market Size by Region

9.4.1 Asia Next Generation Antibody Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Next Generation Antibody Therapeutics Market Size by Region (2018-2023)

9.4.3 Asia Next Generation Antibody Therapeutics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Next Generation Antibody Therapeutics Introduction

11.1.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.1.5 Roche Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Next Generation Antibody Therapeutics Introduction

11.2.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.2.5 Amgen Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Next Generation Antibody Therapeutics Introduction

11.3.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.3.5 Pfizer Recent Developments

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Next Generation Antibody Therapeutics Introduction

11.4.4 Takeda Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.4.5 Takeda Recent Developments

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Introduction

11.5.4 Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.5.5 Daiichi Sankyo Recent Developments

11.6 Seagen

11.6.1 Seagen Company Details

11.6.2 Seagen Business Overview

11.6.3 Seagen Next Generation Antibody Therapeutics Introduction

11.6.4 Seagen Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.6.5 Seagen Recent Developments

11.7 Astellas

11.7.1 Astellas Company Details

11.7.2 Astellas Business Overview

11.7.3 Astellas Next Generation Antibody Therapeutics Introduction

11.7.4 Astellas Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.7.5 Astellas Recent Developments

11.8 Immunomedics

11.8.1 Immunomedics Company Details

11.8.2 Immunomedics Business Overview

11.8.3 Immunomedics Next Generation Antibody Therapeutics Introduction

11.8.4 Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.8.5 Immunomedics Recent Developments

11.9 GSK

11.9.1 GSK Company Details

11.9.2 GSK Business Overview

11.9.3 GSK Next Generation Antibody Therapeutics Introduction

11.9.4 GSK Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.9.5 GSK Recent Developments

11.10 Immunocore

11.10.1 Immunocore Company Details

11.10.2 Immunocore Business Overview

11.10.3 Immunocore Next Generation Antibody Therapeutics Introduction

11.10.4 Immunocore Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.10.5 Immunocore Recent Developments

11.11 ADC Therapeutics

11.11.1 ADC Therapeutics Company Details

11.11.2 ADC Therapeutics Business Overview

11.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Introduction

11.11.4 ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2018-2023)

11.11.5 ADC Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Antibody Drug Conjugate (ADC)

Table 3. Key Players of Bispecific Antibody (BsAb)

Table 4. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Next Generation Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Next Generation Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Next Generation Antibody Therapeutics Market Share by Region (2018-2023)

Table 8. Global Next Generation Antibody Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Next Generation Antibody Therapeutics Market Share by Region (2024-2029)

Table 10. Next Generation Antibody Therapeutics Market Trends

Table 11. Next Generation Antibody Therapeutics Market Drivers

Table 12. Next Generation Antibody Therapeutics Market Challenges

Table 13. Next Generation Antibody Therapeutics Market Restraints

Table 14. Global Next Generation Antibody Therapeutics Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Next Generation Antibody Therapeutics Revenue Share by Players (2018-2023)

Table 16. Global Top Next Generation Antibody Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2022)

Table 17. Global Next Generation Antibody Therapeutics Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Next Generation Antibody Therapeutics Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Next Generation Antibody Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Next Generation Antibody Therapeutics, Product and Application

Table 21. Global Key Players of Next Generation Antibody Therapeutics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2023)

Table 25. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2024-2029)

Table 27. Global Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Next Generation Antibody Therapeutics Revenue Share by Application (2018-2023)

Table 29. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Next Generation Antibody Therapeutics Revenue Share by Application (2024-2029)

Table 31. North America Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Next Generation Antibody Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Next Generation Antibody Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Next Generation Antibody Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Next Generation Antibody Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Next Generation Antibody Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Next Generation Antibody Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Next Generation Antibody Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Next Generation Antibody Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Next Generation Antibody Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Next Generation Antibody Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Next Generation Antibody Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Next Generation Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Next Generation Antibody Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 63. Roche Company Details

Table 64. Roche Business Overview

Table 65. Roche Next Generation Antibody Therapeutics Product

Table 66. Roche Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 67. Roche Recent Developments

Table 68. Amgen Company Details

Table 69. Amgen Business Overview

Table 70. Amgen Next Generation Antibody Therapeutics Product

Table 71. Amgen Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 72. Amgen Recent Developments

Table 73. Pfizer Company Details

Table 74. Pfizer Business Overview

Table 75. Pfizer Next Generation Antibody Therapeutics Product

Table 76. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 77. Pfizer Recent Developments

Table 78. Takeda Company Details

Table 79. Takeda Business Overview

Table 80. Takeda Next Generation Antibody Therapeutics Product

Table 81. Takeda Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 82. Takeda Recent Developments

Table 83. Daiichi Sankyo Company Details

Table 84. Daiichi Sankyo Business Overview

Table 85. Daiichi Sankyo Next Generation Antibody Therapeutics Product

Table 86. Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 87. Daiichi Sankyo Recent Developments

Table 88. Seagen Company Details

Table 89. Seagen Business Overview

Table 90. Seagen Next Generation Antibody Therapeutics Product

Table 91. Seagen Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 92. Seagen Recent Developments

Table 93. Astellas Company Details

Table 94. Astellas Business Overview

Table 95. Astellas Next Generation Antibody Therapeutics Product

Table 96. Astellas Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 97. Astellas Recent Developments

Table 98. Immunomedics Company Details

Table 99. Immunomedics Business Overview

Table 100. Immunomedics Next Generation Antibody Therapeutics Product

Table 101. Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 102. Immunomedics Recent Developments

Table 103. GSK Company Details

Table 104. GSK Business Overview

Table 105. GSK Next Generation Antibody Therapeutics Product

Table 106. GSK Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 107. GSK Recent Developments

Table 108. Immunocore Company Details

Table 109. Immunocore Business Overview

Table 110. Immunocore Next Generation Antibody Therapeutics Product

Table 111. Immunocore Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 112. Immunocore Recent Developments

Table 113. ADC Therapeutics Company Details

Table 114. ADC Therapeutics Business Overview

Table 115. ADC Therapeutics Next Generation Antibody Therapeutics Product

Table 116. ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)

Table 117. ADC Therapeutics Recent Developments

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Next Generation Antibody Therapeutics Market Share by Type: 2022 VS 2029

Figure 3. Antibody Drug Conjugate (ADC) Features

Figure 4. Bispecific Antibody (BsAb) Features

Figure 5. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Next Generation Antibody Therapeutics Market Share by Application: 2022 VS 2029

Figure 7. Cancer Case Studies

Figure 8. Haemophilia Case Studies

Figure 9. Other Non-Cancer Diseases Case Studies

Figure 10. Next Generation Antibody Therapeutics Report Years Considered

Figure 11. Global Next Generation Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Next Generation Antibody Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Next Generation Antibody Therapeutics Market Share by Region: 2022 VS 2029

Figure 14. Global Next Generation Antibody Therapeutics Market Share by Players in 2022

Figure 15. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2022

Figure 17. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

Figure 19. North America Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

Figure 20. North America Next Generation Antibody Therapeutics Market Share by Country (2018-2029)

Figure 21. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Next Generation Antibody Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

Figure 25. Europe Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

Figure 26. Europe Next Generation Antibody Therapeutics Market Share by Country (2018-2029)

Figure 27. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Next Generation Antibody Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

Figure 35. China Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

Figure 36. Asia Next Generation Antibody Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

Figure 38. Asia Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

Figure 39. Asia Next Generation Antibody Therapeutics Market Share by Region (2018-2029)

Figure 40. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Country (2018-2029)

Figure 50. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 57. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 58. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 59. Takeda Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 60. Daiichi Sankyo Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 61. Seagen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 62. Astellas Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 63. Immunomedics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 64. GSK Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 65. Immunocore Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 66. ADC Therapeutics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-12J14669

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical and Consumer Products Coding Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32H12616

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Co-Packing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13K12891

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid-based Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27P12567

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Next Generation Antibody Therapeutics Market Insights, Forecast to 2029

Published Date: September 2023

Report Code: QYRE-Auto-14I13053

Global Next Generation Antibody Therapeutics Market Insights, Forecast to 2029

FEATURED COMPANIES

Next Generation Antibody Therapeutics Market Size

Next Generation Antibody Therapeutics Market

Scope of Next Generation Antibody Therapeutics Market Report

Chapter Outline

FAQ for this report

How fast is Next Generation Antibody Therapeutics Market growing?

What is the Next Generation Antibody Therapeutics Market size in 2029?

What is the market share of major companies in Next Generation Antibody Therapeutics Market?

What is the Next Generation Antibody Therapeutics Market share by region?

What is the Next Generation Antibody Therapeutics Market share by type?

Who are the main players in the Next Generation Antibody Therapeutics Market report?

What are the Application segmentation covered in the Next Generation Antibody Therapeutics Market report?

What are the Type segmentation covered in the Next Generation Antibody Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS